Trials / Conditions / Kidney Transplantation in Highly Sensitized Patients
Kidney Transplantation in Highly Sensitized Patients
5 registered clinical trials studyying Kidney Transplantation in Highly Sensitized Patients — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Imlifidase Prior to Kidney Transplant in Highly Sensitised Children NCT05753930 | Hansa Biopharma AB | Phase 2 |
| Active Not Recruiting | Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx NCT05714514 | Hansa Biopharma AB | — |
| Terminated | A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation NCT05049850 | Hansa Biopharma AB | Phase 2 |
| Active Not Recruiting | Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Coh NCT05369975 | Hansa Biopharma AB | Phase 3 |
| Completed | Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney T NCT04935177 | Hansa Biopharma AB | Phase 3 |